These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3434585)

  • 1. Visual compatibility of esmolol hydrochloride and furosemide in 5% dextrose or 0.9% sodium chloride injections.
    Thompson DF; Thompson GD
    Am J Hosp Pharm; 1987 Dec; 44(12):2740. PubMed ID: 3434585
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Mar; 45(3):630-2. PubMed ID: 2897164
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of esmolol hydrochloride in intravenous solutions.
    Baaske DM; Dykstra SD; Wagenknecht DM; Karnatz NN
    Am J Hosp Pharm; 1994 Nov; 51(21):2693-6. PubMed ID: 7856582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drug additives.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Plitz GW; Cutie AJ
    Am J Hosp Pharm; 1982 Jun; 39(6):1013-5. PubMed ID: 7102682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperatures.
    Pearson SD; Trissel LA
    Am J Hosp Pharm; 1993 Apr; 50(4):698-702. PubMed ID: 8470688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
    Campbell S; Nolan PE; Bliss M; Wood R; Mayersohn M
    Am J Hosp Pharm; 1986 Apr; 43(4):917-21. PubMed ID: 3706337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incompatibility of esmolol hydrochloride and furosemide in a central venous access port.
    Zhao B; Sun W
    Am J Health Syst Pharm; 2014 Jun; 71(11):901-2. PubMed ID: 24830993
    [No Abstract]   [Full Text] [Related]  

  • 9. Compatibility of verapamil hydrochloride injection in commonly used large-volume parenterals.
    Cutie MR; Lordi NG
    Am J Hosp Pharm; 1980 May; 37(5):675-6. PubMed ID: 7386476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5% dextrose injections.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1984 Apr; 41(4):686-9. PubMed ID: 6720710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C.
    Trissel LA; Xu Q; Martinez JF; Fox JL
    Am J Hosp Pharm; 1994 Sep; 51(17):2138-42. PubMed ID: 7527184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of azathioprine sodium with intravenous fluids.
    Johnson CA; Porter WA
    Am J Hosp Pharm; 1981 Jun; 38(6):871-5. PubMed ID: 7246562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids.
    Rosenberg HA; Dougherty JT; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1980 Mar; 37(3):390-2. PubMed ID: 7369222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of flumazenil with selected drugs in 5% dextrose injection.
    Olsen KM; Gurley BJ; Davis GA; Christensen R; Monaghan MS
    Am J Hosp Pharm; 1993 Sep; 50(9):1907-12. PubMed ID: 8135238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of aminophylline with hydrocortisone sodium succinate or dexamethasone sodium phosphate in 5% dextrose injection.
    Jhunjhunwala VP; Bhalla HL
    Am J Hosp Pharm; 1981 Jun; 38(6):900-1. PubMed ID: 7246567
    [No Abstract]   [Full Text] [Related]  

  • 16. Incompatibility of labetalol hydrochloride and furosemide.
    Zeisler J; Alagna C
    Am J Hosp Pharm; 1993 Dec; 50(12):2521-2. PubMed ID: 8122682
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
    Perentesis GP; Piltz GW; Kirshcenbaum HL; Navalakha P; Aronoff W; Cutie AJ
    Am J Hosp Pharm; 1983 Jun; 40(6):1010-2. PubMed ID: 6869385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulation.
    Macias JM; Martin WJ; Lloyd CW
    Am J Hosp Pharm; 1985 May; 42(5):1087-94. PubMed ID: 3923832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of clindamycin phosphate with cefotaxime sodium or netilmicin sulfate in small-volume admixtures.
    Foley PT; Bosso JA; Bair JN; Townsend RJ
    Am J Hosp Pharm; 1985 Apr; 42(4):839-43. PubMed ID: 4014236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers.
    Cummings DS; Park MK; Howard AB
    Am J Hosp Pharm; 1982 Oct; 39(10):1685-7. PubMed ID: 7148843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.